Skip to main content

Modified Release Solid Oral Dosage Forms

  • Chapter
  • First Online:
Essential Pharmaceutics

Abstract

This chapter presents an extensive overview of the concepts of delayed-release, sustained-release, and pulsatile-release for drug delivery. Formulation approaches and delivery technologies are discussed in detail, along with the required performance testing for modified-release dosage forms. Abuse-deterrent technologies are also introduced.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Suggested readings for the student include the following texts:

    Google Scholar 

  2. Food and Drug Administration Center for Drugs Evaluation Research. Abuse-deterrent opioids-evaluation and labeling. Maryland: FDA; 2015.

    Google Scholar 

  3. Conte U, Maggi L, Torre ML, Giunchedi P, La Manna A. Press-coated tablets for time-programmed release of drugs. Biomaterials. 1993;14(13):1017–23.

    Article  CAS  Google Scholar 

  4. Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. Int J Pharm. 2016;510(1):57–72.

    Article  CAS  Google Scholar 

  5. Miller DA, DiNunzio JC, Williams RO III. Advanced formulation design: improving drug therapies for the management of severe and chronic pain. Drug Dev Ind Pharm. 2008;34:117–33.

    Article  CAS  Google Scholar 

  6. Miller DA, Gamba M, Sauer D, Purvis TP, Clemens NT, Williams RO III. Evaluation of the USP dissolution test method a for enteric-coated articles by planar laser-induced fluorescence. Int J Pharm. 2007;330:61072.

    Article  Google Scholar 

  7. Perucca E. Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilep Curr. 2009;9(6):153–7.

    Article  Google Scholar 

  8. Rhodes CT, Porter SC. Coatings for controlled-release drug delivery systems. Drug Dev Ind Pharm. 1998;24(12):1139–54.

    Article  CAS  Google Scholar 

  9. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release. 2009;134(2):74–80.

    Article  CAS  Google Scholar 

  10. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release. 2002;79(1–3):7–27.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 American Association of Pharmaceutical Scientists

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Brunaugh, A.D., Smyth, H.D.C., Williams III, R.O. (2019). Modified Release Solid Oral Dosage Forms. In: Essential Pharmaceutics. AAPS Introductions in the Pharmaceutical Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-31745-4_4

Download citation

Publish with us

Policies and ethics